Recent insider trading activity from Steik Jason Paul, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Pennant Group, Inc. | $PNTG | Steik Jason Paul | Chief Clinical Officer | A | Stock Option (right to buy) | 26000 | $33.30 | 26,000.0000 | 35,274,000 | 9999.99% | 0.07% |